MagForce enters into preclinical research agreement to investigate NanoTherm® therapy in the gastrointestinal cancer field in the USA
04:50 EDT 22 Jun 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
MagForce AG /
MagForce enters into preclinical research agreement to investigate NanoTherm®
therapy in the gastrointestinal cancer field in the USA
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of ...
Other Sources for this Article
More From BioPortfolio on "MagForce enters into preclinical research agreement to investigate NanoTherm® therapy in the gastrointestinal cancer field in the USA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
